A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial

U Jaisamrarn, S Chaovisitsaree, S Angsuwathana… - Contraception, 2014 - Elsevier
Objective This study aimed to compare the effectiveness and safety of triphasic combined
oral contraceptives (OCs) containing ethinyl estradiol (EE) and norgestimate (NGM) and …

Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris …

PG Sator, JB Schmidt, H Hönigsmann - Dermatology, 2003 - karger.com
Abstract Background and Objective: The aim of this study was to evaluate the efficacy of a
triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol …

Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate

M Vartiainen, H De Gezelle… - The European Journal of …, 2001 - Taylor & Francis
Objective: To investigate the effect of a combiphasic oral contraceptive containing
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …

The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review

G Grandi, G Guariglia, F Facchinetti - The European Journal of …, 2023 - Taylor & Francis
Abstract Introduction Both Food and Drugs Administration and European Medicine Agency
(EMA) approve the use of a triphasic combined oral contraceptive (COC) containing ethinyl …

A randomized controlled trial of second-versus third-generation oral contraceptives in the treatment of acne vulgaris

MP Rosen, DM Breitkopf, M Nagamani - American journal of obstetrics and …, 2003 - Elsevier
Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial

GP Redmond, WH Olson, JS Lippman… - Obstetrics & …, 1997 - Elsevier
OBJECTIVE: To evaluate the efficacy of a triphasic, combination oral contraceptive
(OC),(norgestimate-ethinyl estradiol), in comparison with placebo in the treatment of …

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo …

E Palombo-Kinne, I Schellschmidt, U Schumacher… - Contraception, 2009 - Elsevier
BACKGROUND: Acne is a multifactorial disease characterized by androgenic stimulation of
sebaceous glands. Therefore, combined oral contraceptives (COCs) containing anti …

Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a …

W Koltun, JM Maloney, J Marr, M Kunz - European Journal of Obstetrics & …, 2011 - Elsevier
OBJECTIVE: To investigate the effects of an ethinylestradiol (EE) 20μg/drospirenone (drsp)
3mg combined oral contraceptive (COC) administered in a 24/4 regimen (24 active tablets/4 …

The role of combined oral contraceptives in the management of acne and seborrhea

V Del Marmol, A Teichmann… - The European Journal of …, 2004 - Taylor & Francis
Acne and seborrhea (or facial oiliness) are related androgenic skin disorders which affect a
high proportion of women after menarche. They can have a negative effect on psychological …

The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.

WH Olson, JS Lippman, DM Robisch - International journal of fertility …, 1998 - europepmc.org
Objective This was a postmarketing, retrospective, exploratory analysis to investigate the
duration of response to a triphasic combination oral contraceptive (OC)(Ortho Tri-Cyclen; …